ABT · News · 20260915N

Infant Formula Litigation

ABBOTT LABORATORIES · 2026-09-15 · Importance 40 · Surprise 42

Abbott agreed to pay $385 million to resolve U.S. Justice Department allegations related to contaminated infant formula produced during a 2022 investigation that led to the closure of its largest plant. The settlement resolves False Claims Act claims without an admission of fault, and three whistleblowers will receive $69 million. Abbott continues to face related infant-formula litigation, including a $495 million jury award that was affirmed on appeal, bringing the reported settlement and award exposure to approximately $880 million.

Key facts

• Abbott continues to face ongoing litigation related to its infant formula business, including a $495 million jury award affirmed on appeal. source